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Abstract: Telomerase dysfunction contributes to cellular senescence. Recent advances indicate 
the importance of senescence in maintaining vascular cell function in vitro. Human telomerase 
reverse transcriptase (hTERT) overexpression is thought to lead to resistance to apoptosis and 
oxidative stress. However, the mechanism in endothelial lineage cells is unclear. We tried to 
generate an immortal endothelial cell line from human umbilical vein endothelial cells using a 
no-virus system and examine the functional mechanisms of hTERT overexpressed endothelial 
cell senescence in vitro. High levels of hTERT genes and endothelial cell-speciﬁ  c markers were 
expressed during long-term culture. Also, angiogenic responses were observed in hTERT over-
expressed endothelial cell. These cells showed a delay in senescence and appeared more resistant 
to stressed conditions. PI3K/Akt-related gene levels were enhanced in hTERT overexpressed 
endothelial cells. An up-regulated PI3K/Akt pathway caused by hTERT overexpression might 
contribute to anti-apoptosis and survival effects in endothelial lineage cells.
Keywords: endothelial, telomerase, senescence, oxidative stress, anti-apoptosis, PI3K/Akt 
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In vitro, normal somatic cells undergo a non-dividing state termed cellular replicative 
senescence (Harley et al 1990; Hastie et al 1990; Wright and Shay 1992). The erosion 
of telomeres, a reverse transcriptase synthesize telomeric DNA, has been suggested to 
contribute to cellular replicative senescence (Greider 1990; Nakamura et al 1997). It 
is necessary to increase the number of human endothelial progenitor cells (EPCs) in 
vitro to obtain large numbers for research and cell transplantation. A potential obstacle 
to this increase, however, is the fact that EPCs, as well as other somatic cells, have a 
limited replication lifespan.
Human telomerase reverse transcriptase (hTERT)-transduced differentiated endo-
thelial cell (ECs) exhibit neither evidence of malignant transformation nor loss of 
functional and morphologic characteristics of parental cells (Yang et al 1999). These 
ﬁ  ndings support the stability of endothelial lineage cells after hTERT overexpression. 
We previously reported on the therapeutic potential of adenoviral hTERT overex-
pressed endothelial lineage cells in an ischemic hindlimb mouse model (Murasawa 
et al 2002). However, ectopic hTERT expression by adenovirus transduction was 
limited to 4 weeks and did not lead to immortal EPCs. We had expected that the 
enhanced regenerative activity of EPCs by hTERT transduction would provide a 
novel therapeutic strategy for potential neovascularization in patients with severe 
ischemic disease. However, the mechanism by which hTERT-transduced EC lines 
appear more resistant to programmed cell-death and exhibit a survival advantage 
beyond replicative senescence is elusive. Thus, further investigation of the possible 
mechanistic pathways is needed.
Here we perform gene transfer with a no-virus system to transduce hTERT genes 
into human umbilical vein endothelial cells (HUVECs), one of the endothelial lineage Biologics: Targets & Therapy 2008:2(3) 548
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cell models, to investigate the relation between senescence 
and telomerase in vitro, determine the possible mechanistic 
pathways, and investigate the characteristics of these cells 
for future clinical application.
Materials and methods
Reagents
Recombinant human VEGF165 and bFGF were purchased 
from R&D Systems Inc. (Minneapolis, MN, USA). Hoechst 
33342 solution was purchased from Dojin Chemical Labora-
tory (Kumamoto, Japan).
Cell culture and gene transfer
HUVECs were grown in endothelial cell growth media 
EGM-2 Bullet kit (CAMBREX, Walkersville, MD, USA) 
supplemented with 2% fetal bovine serum (CAMBREX). 
The cDNA encoding hTERT was cloned downstream of the 
human cytomegalovirus (CMV) promoter in pcDNA3.1(+) 
(Invitrogen, Carlsbad, CA, USA) with LipofectamineTM 
2000 (Invitrogen). Forty-eight hours after transfection, the 
transfected-cell populations were selected with 600 μg/mL 
of G418 (GIBCO, Grand Island, NY). Cells transfected with 
empty vectors were used as controls. Population doublings 
(PD) were calculated as follows: PD = log (number of cells 
obtained/initial number of cells)/log 2.
RT-PCR for telomerase transcripts
Total RNA was isolated with an RNA extraction kit (Ambion, 
Austin, TX, USA). DNase digestion was performed after 
RNA extraction. cDNA was synthesized by AMV First-
strand Synthesis System (Takara Bio, Shiga, Japan). PCR 
reaction of hTERT and endothelial markers were performed 
by a system according to the manufacture (BD Biosciences, 
San Diego, CA and Applied Biosystems, Foster City, CA, 
USA). The primers for RT-PCR are shown in Table 1.
Senescence-associated (SA)-
Galactosidase (Gal) Staining
4 x 104 cells were plated on 12-well plates pre-coated with 
ﬁ  bronectin and cultivated in growth medium for 24 hours. 
Senescence was investigated by a SA-Gal activity assay 
system according to the manufacture (CALBIOCHEM, San 
Diego, CA, USA). Quantiﬁ  cation of SA-Gal–positive cells 
was obtained by counting ﬁ  ve random ﬁ  elds per dish and 
assessing the percentage.
Proliferation assay
3.5 x 103 cells grown in 96-well plates pre-coated with ﬁ  bro-
nectin were cultivated in growth medium for 24 hours then in 
basal medium for another 24 hours. Then the culture medium 
was changed to basal medium in the presence of angiogenic 
cytokines for 24 hours. Proliferative activity was evaluated 
using the MTS assay (Promega, Madison, WI, USA).
Apoptosis assay
1 x 105 cells grown in 12-well plates pre-coated with ﬁ  bro-
nectin were cultivated in growth medium for 24 hours then in 
basal medium for another 24 hours. To detect the frequency of 
cellular apoptosis, ﬂ  uorescence-labeled Annexin-V-FLUOS 
staining of transduced HUVECs was performed according to 
manufacture’s instructions (Roche Molecular Biochemicals, 
Mannheim, Germany). Quantiﬁ  cation of Annexin-V positive 
cells was obtained by counting 5 random ﬁ  elds per dish and 
assessing the percentage.
Oxidative stress detection assay
1 x 105 cells were grown in 12-well plates pre-coated with 
ﬁ  bronectin cultivated in growth medium. After 24 hours’ 
incubation, the cells were incubated with 1mM H2O2 in 
HEPES buffer for 1 hour. Then the medium was changed to 
growth medium for another 3 hours. Detection of oxidative 
damage in live cells was performed using the Image-iTTM 
LIVE Green Reactive Oxygen Species (ROS) Detection 
Kit (Molecular Probes, Eugene, OR, USA). Quantiﬁ  cation 
of ROS detected cells was obtained by counting 5 random 
ﬁ  elds per dish and assessing the percentage.
Gene array analysis
Targeted cDNA arrays designed to analyze endothelial cell 
biology, angiogenesis, apoptosis, cell cycle, and PI3K/Akt 
pathway (GEArray HS-036, HS-009, HS-603, and HS-058) 
  Table 1 List of primer sequences for PCR
Molecule  Sense (5’–3’)  Antiense (5’–3’)
hTERT CACCTCACCTCACCCACGCGAAA  CCAAAGAGTTTGCGACGCATGTT
hCD31 AGGACATCCATGTTCCGAGA  TGAACCGTGTCTTCAGGTTG
hKDR CCCTGCCGTGTTGAAGAGTT  GGACAGGGGGAAGAACAAAA
heNOS TTACCATGGCAACCAACGTC  AAAAGCTCTGGGTGCGTATG
hGAPDH GCCCCAGCAAGAGCACAAGA  TAGGCCCCTCCCCTCTTCAABiologics: Targets & Therapy 2008:2(3) 549
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were purchased from SuperArray Bioscience Corporation 
(Frederick, MD, USA). Hybridization was quantiﬁ  ed using 
a Luminescent Image Analyzer LAS-3000 (Fujiﬁ  lm, Tokyo, 
Japan) and data analysis was performed using Science Lab 
2001 Image Gauge (Fujiﬁ  lm) software. The background was 
subtracted from each representing dot signal, and values were 
normalized according to the GAPDH signal.
Statistical analysis
All values are expressed as mean ± SD. Comparisons of 
results between different groups were performed using 
Student’s t test.
Results
hTERT transduced HUVECs expressed 
telomerase gene during long term culture
hTERT transduced HUVECs (Td/TERTs) were isolated 
from several donors cell sources. RT-PCR analysis showed 
that telomerase gene expression was maintained during 
long term culture, and the level achieved in Td/TERTs was 
comparable to that expressed by the 293 human embryonic 
kidney tumor cell lines (Figure 1A). By contrast, mock 
transduced HUVECs (Td/mocks) did not express endogenous 
telomerase at early cultures (data not shown). Further, the 
transduced HUVECs expressed endothelial markers such as 
CD31, KDR, and eNOS during long term culture (Figure 1B). 
Sequences of PCR primers are shown in Table 1.
Transduced HUVEC lines maintained 
endothelial characteristics
Phenotypes of these cell lines displayed serum-dependence 
for growth (Figure 2A) and normal contact inhibition 
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Figure 1 hTERT transduced HUVECs expressed telomerase genes during long-term 
culture. RNA samples from transduced HUVECs were analyzed by RT-PCR for gene 
expression. (A) Expression of hTERT gene in 293 cells served as the positive standard. 
(B) Expression of endothelial markers.
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Figure 2   Transduced HUVEC lines maintained endothelial characteristics. (A) Growth 
of transduced HUVECs, Td/mock (day 159) and Td/TERT (day 124), was inhibited in 
low serum (*p  0.001, ** p  0.05). (B) Growth curves of transduced HUVEC. About 
in a month, most transduced HUVECs showed almost a typical senescent endothelial 
morphology and stopped continuous growth. However, hTERT overexpression allowed 
the maintanance of a relatively normal endothelial morphology during the aging process. 
(C) Phase microscopy demonstrated endothelial morphology of Td/TERTs (day 96) 
and Td/mocks (day 25). Original magniﬁ  cation x100.Biologics: Targets & Therapy 2008:2(3) 550
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(data not shown). Thus, the transduced HUVEC lines 
showed no signs of tumorigenic transformation. About in a 
month, transduced HUVECs ordinary entered the growth-
arrested state (Figure 2B), and these phenotypes developed 
an enlarged and ﬂ  attened morphology (Figure 2C, Td/mocks 
[day 25]). In contrast, the Td/TERTs (day 96) maintained a 
relatively normal endothelial morphology during the aging 
process (Figure 2C). However, some Td/mocks survived 
more than a month and maintained the same normal endo-
thelial morphology as the Td/TERTs (data not shown).
Transduced HUVEC senescence 
evaluated by SA-Gal staining
The cytochemical senescent phenotype was also examined 
using SA-Gal activity. As expected, hTERT expression 
facilitated the delay in senescence (Figure 3A, B). During 
the aging process, transduced HUVECs revealed SA-Gal 
activity. However, the ratio to total cells in Td/mocks (day 32) 
was signiﬁ  cantly increased compared with that in Td/TERTs 
(day 105) (41% ± 13% vs 7% ± 4%, p  0.001). These results 
indicated that hTERT overexpression delayed the cells from 
entering their senescent state.
hTERT overexpression exceeded 
mitogenic potential.
Endothelial cell lines have a mitogenic response to angio-
genic cytokines. To determine whether Td/TERTs produced 
angiogenic responses on stimulation by growth factors, 
we performed angiogenic proliferation assays by treating 
transduced HUVECs with different cytokines in VEGF165 
and bFGF while applying serum-depleted basal EBM-2 
medium. As shown in Figure 3C, D, when treated with 
VEGF165 (Figure 3C) and bFGF (Figure 3D), MTS assay 
showed signiﬁ  cantly increased proliferation in Td/TERTs 
Figure 3 Senescence in transduced HUVECs was evaluated by SA-Gal staining. (A) Quantiﬁ  cation of SA-Gal–positive cells in transduced HUVECs obtained by counting 
5 random ﬁ  elds per dish (p  0.001 vs Td/mocks). (B) Representative photomicrographs show SA-Gal–positive cells (blue) in Td/TERTs (day 105) and Td/mocks (day 32). 
Original magniﬁ  cation x100. hTERT overexpression exceeded mitogenic potential. (C) Proliferative activity assay response to VEGF165. (D) Proliferative activity assay response 
to bFGF. The increase in mitogenic response to angiogenic cytokines of Td/TERTs (day 73) was statistically signiﬁ  cant compared with Td/mocks (day 59) (VEGF: p  0.001; 
bFGF: p  0.001 vs Td/mocks).
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(at day 73) than that in Td/mocks (at day 59) (VEGF; 0.506 
nm ± 0.061 nm vs 0.239 nm ± 0.013 nm, p  0.001, bFGF; 
0.697 nm ± 0.067 nm vs 0.261 nm ± 0.027 nm, p  0.001). 
These data suggest that Td/TERTs generate more remark-
able angiogenic responses to angiogenic cytokines, perhaps 
as part of their general endothelial function, than that of 
Td/mocks.
hTERT transduction contributes to cell 
survival
To conﬁ  rm whether hTERT modulates cell survival, cell 
apoptosis and oxidative damage were evaluated in transduced 
HUVECs. Strong Annexin-V (green) staining, corresponding 
to apoptotic cells, was observed in Td/mocks (Figure 4A). The 
staining indicated that serum starvation-induced apoptosis 
was markedly reduced in Td/TERTs (Figure 4, B) 
(4.9% ± 1.5% vs 54.9% ± 11.0%, p  0.001). Furthermore, 
strong carboxy-H2DCFDA (green) staining, corresponding 
to oxidized by ROS, was observed in Td/mocks (Figure 4C). 
The oxidatively damaged cells signiﬁ  cantly increased in 
Td/mocks (10.3% ± 2.2% vs 42.1% ± 6.7%, p  0.001) 
(Figure 4, D). Staining in blue indicated nuclei by Hoechst 
33342 (Figure 4A, C) Taken together, these results suggest 
that hTERT overexpression in HUVECs contributes to 
resisting apoptosis and oxidative damage.
Gene expression up-regulated in hTERT 
HUVEC
Finally we examined gene levels of transduced HUVECs. To 
explore the genes involved in hTERT-induced cell survival, 
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Figure 4 hTERT transduction contributes to cell survival. (A) Representative photomicrographs show Annexin-V (green), propidium iodide (red), and nuclei were stained 
with blue-ﬂ  uorescent Hoechst 33342. Original magniﬁ  cation x100. (B) Quantiﬁ  cation of apoptosis-induced. The number of apoptotic cells was signiﬁ  cantly increased in 
Td/mocks (p  0.001) vs Td/TERTs. (C) Oxidative stress measurement in live cells. Representative photomicrographs show the cells stained with carboxy-H2DCFDA (green), 
corresponding to oxidized cells by ROS, and nuclei were stained with blue-ﬂ  uorescent Hoechst 33342. Original magniﬁ  cation x100. (D) Quantiﬁ  cation of oxidatively damaged 
cells. The oxidatively damaged cells signiﬁ  cantly increased in Td/mocks (p  0.001) vs Td/TERTs.Biologics: Targets & Therapy 2008:2(3) 552
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we applied cDNA microarray to transduced HUVECs. We 
compared the endothelial cell biology, angiogenesis, PI3K/
Akt signaling pathway, apoptosis, and cell cycle gene expres-
sion proﬁ  les of Td/mocks (day 46) and Td/TERTs (day 60). 
Microarray analysis revealed that hTERT overexpression 
altered expression of various genes related to apoptosis, cell 
survival, and signal transduction molecules. As shown in 
Table 2, survival signals such as PI3K/Akt related gene levels 
were enhanced in hTERT overexpressed HUVECs.
Discussion
Functional changes in senescent endothelial cells in vivo 
may play an important role in the pathophysiology of age-
associated vascular disorders. Thus, recovery of endothelial 
cell proﬁ  les could have possible clinical advantages in some 
cases. Recently, transduction of hTERT has been used to 
generate immortal cells. Various approaches have been used, 
none of which convert the cells to a transformed phenotype 
(Bodnar et al 1998; Jiang et al 1999; Morales et al 1999; 
Table 2 Gene array analysis of transduced HUVECs
  Gene bank Symbol Gene name Description
AKT and PI3K Family Members and Their Regulators
NM021158 C20orf97 TRB3 Chromosome 20 open reading frame 97 ++
NM002074 GNB1 GNB1 Guanine nucleotide binding protein (G protein), beta polypeptide 1 ++
NM000883 IMPDH1 IMPDH1 IMP (inosine monophosphate) dehydrogenase 1 +++
NM005541 INPP5D SHIP Inositol polyphosphate-5- phosphatase,145kDa ++
NM014221 MTCP1 MTCP1 Mature T-cell proliferation 1 ++
NM006218 PIK3CA p110alpha phosphoinositide-3kinase, catalytic, alpha polypeptide ++
NM006219 PIK3CB p110beta phosphoinositide-3kinase, catalytic, beta polypeptide ++
NM003629 PIK3R3 p55 gamma Phosphoinositide-3-kinase,regulatory subunit, polypeptide 3 (p55, gamma) +++
NM181897 PPP2R3A PPP2R3A Protein phosphatase 2 (formerly 2A), regulatory subunit B, alpha ++
NM006246 PPP2R5E PPP2R5E Protein phosphatase 2, regulatory subunit B, (B56), epsilon isoform ++
NM002737 PRKCA PKC alpha Protein kinase C, alpha +++
PI3K-Dependent/AKT -Dependent Pathways
NM002093 GSK3B GSK3 Glycogen synthase kinase 3 beta ++
NM005923 MAP3K5 MEKK5/ASK1 Mitogen-activated protein kinase kinase kinase 5 +++
Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophia);
NM005938 MLLT7 AFX1 translocated to,7 ++
NM002467 MYC c-Myc V-myc myelocytomatosis viral oncogene homolog (avian) +++
NM003998 NFKB1 KBF1 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) +++
NM020529 NFKBIA IKBA/MAD-3 Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha +++
NM001278 CHUK IKKA/IKK1 Conserved helix-loop-helix ubiquitous kinase +++
NM002576 PAK1 Pak1 P21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast) +++
NM012296 GAB2 GAB2 GRB2-associated binding protein 2 +++
Apoptosis Panel for Monitoring Cell Programmed Death and Survival
NM004536 BIRC1 NAIP Baculoviral IAP repeat-containing protein 1 (Neuronal apoptosis inhibitory protein) ++
NM003810 TNFSF10 TRAIL Tumor necrosis factor (ligand) superfamily member, 10 +
NM003701 TNFSF11 TRANCE Tumor necrosis factor (ligand) superfamily member, 11 ++
NM003811 TNFSF9 4-1BB-L Tumor necrosis factor (ligand) superfamily member, 9 +
NM001561 TNFRSF9 4-1BB Tumor necrosis factor receptor superfamily member, 9 +++
Stress & Toxicity Panel for Monitoring the Type of Stress Induced
NM002983 CCL3 MIP-1a/SCYA3 Chemokine (C-C motif) ligane 3 (Macrophage inﬂ  ammatory protein 1-alpha) +
NM021027 UGT1A9 UGT1A9 UDP glycosyltransferase 1 family, polypeptide A9 ++
cDNA microarrays were performed to analyze the gene expression of transduced HUVECs. PI3K/Akt related gene levels were enhanced in Td/hTERTs compared with 
Td/mocks.
+: 2- to < 4-fold up-regulation in Td/hTERT,  ++: 4- to < 10-fold up-regulation in Td/hTERT, +++: 10- or > 10-fold up-regulation in Td/hTERT compared with Td/mock.Biologics: Targets & Therapy 2008:2(3) 553
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Gagnon et al 2002; Yang et al 1999). Virus systems are the 
most efﬁ  cient way to deliver genes to cells. However, the 
clinical applications of viral vectors are limited because of 
the intrinsic properties of viruses. Therefore, it seems that 
no-virus approaches of somatic gene delivery are preferable. 
In this regard, we tried to generate endothelial cell lines by 
ectopic expression of hTERT in HUVEC using a no-virus 
system.
Several interesting functional properties were noted in 
our experiments. First, Td/hTERT retained high level hTERT 
gene expression during long-term culture, and the cells stably 
expressed typical endothelial cell markers, including CD31, 
KDR, and eNOS. In agreement with other reports (Yang et al 
1999; Nisato et al 2004; Freedman and Folkman 2004; Shao 
and Guo 2004), hTERT expression exhibited contact inhibi-
tion and serum-dependent cell proliferation, and did not show 
signs of tumorigenic transformation. Second, Td/hTERT cell 
lines had signiﬁ  cant mitogenic activity in response to angio-
genic cytokines compared with Td/mocks. Third, hTERT 
induced a delay in senescence and hTERT overexpressed 
cells appeared more resistant to stressed conditions. Fourth, a 
variety of genes related to cell survival were enhanced in Td/
hTERT. In contrast to the immortalization shown in previous 
reports (Yang et al 1999; Nisato et al 2004; Freedman and 
Folkman 2004; Shao and Guo 2004), our system did not 
establish immortalized endothelial cells, but led to improved 
functional integrity as well as adenovirus transduction. For 
immortalization, Kiyono et al (1998) demonstrated that 
telomerase activity was not sufﬁ  cient for immortalization of 
human kerationocyte or mammary epithelial cells. It likely 
that additional activities of antisenescent genes may be 
required to maintain functional integrity. Moreover, for gene 
transfer with potential therapeutic efﬁ  ciency, immortalization 
is not necessarily valuable for clinical approaches.
Our results imply that telomerase inhibited functional 
alterations associated with senescence in endothelial cells. 
Thus we tried to study the molecular proﬁ  le and mechanisms 
of apoptotic resistance and the ability to delay senescence.
Several factors, such as oxidative stress and DNA 
damage, have been shown to cause endothelial dysfunction. 
Recent studies showed that introduction of TERT into 
human vascular cells increased longevity and functional 
activity of endothelial cells (Yang et al 1999), suggesting 
that telomere function is necessary for endothelial function. 
Endothelial cell aging is linked to an increase in intracellular 
ROS formation, which in turn affects TERT localization 
and activity (Haendler et al 2004), and oxidative stress-caused 
perturbation of antioxidant mechanisms results in decreased 
telomeric integrity in endothelial cells (Kurz et al 2004). 
Moreover, reduction of nuclear TERT during endothelial 
cell aging increases the sensitivity of aged endothelial cells 
toward apoptotic stimuli (Assmus et al 2003). Thus recent 
studies have gradually elucidated the function of TERT in 
regulating a delay in endothelial cell senescence.
Our gene array data suggest that the PI3K/Akt-related 
gene levels were enhanced in Td/hTERT. The serine/threonine 
kinase Akt, activated by various growth and survival factors 
through a pathway that requires PI3K-dependent, has been 
shown to regulate multiple biological processes and also acts 
as an anti-apoptosis protein (Franke et al 1997; Crowder et al 
1998; Eves et al 1998; Ulrich et al 1998). In case of endothelial 
cell, it has been shown to act downstream of angiogenic 
growth factors VEGF and angiopoietin, and contributes 
to endothelial cell survival, proper vessel development 
(Gerber et al 1998; Kontos et al 1998; Carmeliet et al 1999; 
Kim et al 2000; Papapetropoulos et al 2000), formation 
of vascular structures in vitro (Kureishi et al 2000), and 
regulates endothelial cell nitric oxide production in response 
to VEGF (Luo et al 2000). Recently, Zaccagnini et al (2005) 
demonstrated that telomerase mediates VEGF-dependent 
responsiveness in the rat ischemic hindlimb model. They 
introduced the idea that hTERT behaves as an angiogenic 
factor and a downstream effector of VEGF signaling, and 
that telomerase activity appears to be required for VEGF-
dependent remodeling of ischemic tissue at the capillary 
and arteriole level. They hypothesized that the function of 
hTERT, at least in vascular cells, might be controlled by a 
molecular network of autoregulatory loops in which growth 
factor production plays an important role.
Furthermore, recent studies suggest that ROS works as a 
regulator of signal transduction (Griendling and Ushio-Fukai 
2000). Nishida et al (2000, 2002) reported that heterotrimeric 
Gi/o proteins are putative target molecules of ROS and the 
βγ-subunit of G protein (Gβγ) liberated from Gi and Go by 
oxidative stress activates PI3K, which in turn leads to activa-
tion of Akt and ERK. They hypothesized that the intracellular 
signal transduction induced by the Gβγ of Gi and Go may 
protect cells against oxidative stress as part of their normal 
cellular function. It is possible that Td/hTERT obtained 
during normal cellular function against stress conditions, 
as well as stable nuclear TERT obtained during cell aging, 
might cause the activation of PI3K/Akt-related gene levels 
and protect cells against various stress conditions.
We are trying to determine the various potentials of 
hTERT in endothelial cells. The knowledge gained from 
the further study of telomerase overexpressed endothelial Biologics: Targets & Therapy 2008:2(3) 554
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cells might help explain effects on cell survival. Further 
mechanistic investigations could contribute to improvements 
in vascular disorders in terms of the selection of cell sources 
when patients undergo cell transplantation.
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